Literature DB >> 9184186

TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma.

D G Powe1, J L Brough, G I Carter, E M Bailey, W G Stetler-Stevenson, D R Turner, R E Hewitt.   

Abstract

In this study, we report on the distribution of tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) mRNA expression in human normal colorectal mucosa, adenomas and adenocarcinomas. Northern blot analysis showed five TIMP-3 mRNA transcripts to be present in normal mucosal epithelium and in moderately and poorly differentiated carcinoma. Adenomas and well-differentiated carcinomas were not examined in this part of the investigation. In situ hybridization studies showed no detectable TIMP-3 mRNA in normal and adenomatous tissue. In contrast, TIMP-3 mRNA is localized to stromal fibroblast-like cells in colorectal carcinomas, with an increased incidence in moderately and poorly differentiated groups compared with well-differentiated carcinomas. Expression in both the moderately and the poorly differentiated tumour groups was strongest at the tumour invasive edge; none of the poorly differentiated carcinomas showed mRNA expression in regions ahead of the invasive edge, compared with 3 of 12 of the moderate group. To our knowledge, this is the first detailed report on the regional localization of TIMP-3 mRNA in colorectal tumours. We suggest that the lack of TIMP-3 mRNA expression in host stromal tissues ahead of poorly differentiated carcinomas may contribute to their increased invasiveness.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184186      PMCID: PMC2223522          DOI: 10.1038/bjc.1997.285

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium.

Authors:  G S Firestein; M M Paine
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

Review 2.  Tumor invasion and metastasis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; W G Stetler-Stevenson
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

3.  Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours.

Authors:  R E Hewitt; I H Leach; D G Powe; I M Clark; T E Cawston; D R Turner
Journal:  Int J Cancer       Date:  1991-11-11       Impact factor: 7.396

4.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.

Authors:  A J Docherty; A Lyons; B J Smith; E M Wright; P E Stephens; T J Harris; G Murphy; J J Reynolds
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

5.  Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia.

Authors:  R Poulsom; M Pignatelli; W G Stetler-Stevenson; L A Liotta; P A Wright; R E Jeffery; J M Longcroft; L Rogers; G W Stamp
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

6.  TIMP1 and adverse prognosis in non-small cell lung cancer.

Authors:  K M Fong; Y Kida; P V Zimmerman; P J Smith
Journal:  Clin Cancer Res       Date:  1996-08       Impact factor: 12.531

Review 7.  Type IV collagenases in tumor invasion and metastasis.

Authors:  W G Stetler-Stevenson
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

8.  Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

Authors:  W G Stetler-Stevenson; H C Krutzsch; L A Liotta
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

9.  The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: an in situ hybridization and immunocytochemical study.

Authors:  P V Senior; D R Critchley; F Beck; R A Walker; J M Varley
Journal:  Development       Date:  1988-11       Impact factor: 6.868

10.  Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA.

Authors:  S Nomura; B L Hogan; A J Wills; J K Heath; D R Edwards
Journal:  Development       Date:  1989-03       Impact factor: 6.868

View more
  13 in total

Review 1.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 2.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

3.  Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.

Authors:  M Vaalamo; M L Karjalainen-Lindsberg; P Puolakkainen; J Kere; U Saarialho-Kere
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

4.  TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles.

Authors:  Hanne Offenberg; Nils Brünner; Francisco Mansilla; F Orntoft Torben; Karin Birkenkamp-Demtroder
Journal:  Mol Oncol       Date:  2008-06-18       Impact factor: 6.603

5.  Methylation of TIMP3 in esophageal squamous cell carcinoma.

Authors:  Eric Smith; Neville J De Young; Zi-Qiang Tian; Maria Caruso; Andrew R Ruszkiewicz; Jun-Feng Liu; Glyn G Jamieson; Paul A Drew
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

6.  Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer.

Authors:  Mohammad Obaidul Hoque; Shahnaz Begum; Mariana Brait; Carmen Jeronimo; Marianna Zahurak; Kimberly Laskie Ostrow; Eli Rosenbaum; Bruce Trock; William H Westra; Mark Schoenberg; Steven N Goodman; David Sidransky
Journal:  J Urol       Date:  2007-12-20       Impact factor: 7.450

7.  DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis.

Authors:  Kazuo Konishi; Yoshiyuki Watanabe; Lanlan Shen; Yi Guo; Ryan J Castoro; Kimie Kondo; Woonbok Chung; Saira Ahmed; Jaroslav Jelinek; Yanis A Boumber; Marcos R Estecio; Shinji Maegawa; Yutaka Kondo; Fumio Itoh; Michio Imawari; Stanley R Hamilton; Jean-Pierre J Issa
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

8.  Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.

Authors:  L L Groft; H Muzik; N B Rewcastle; R N Johnston; V Knäuper; M A Lafleur; P A Forsyth; D R Edwards
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

9.  An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma.

Authors:  T Miyazaki; H Kato; M Nakajima; A Faried; J Takita; M Sohda; Y Fukai; S Yamaguchi; N Masuda; R Manda; M Fukuchi; H Ojima; K Tsukada; H Kuwano
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

10.  Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.

Authors:  K Airola; T Karonen; M Vaalamo; K Lehti; J Lohi; A L Kariniemi; J Keski-Oja; U K Saarialho-Kere
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.